Acadian Asset Management
IRD

Acadian Asset Management’s Opus Genetics IRD Stock Holding History

Acadian Asset Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-49,563
Closed -$165K – 1851
2023
Q3 		$165K Buy
49,563
+21,318
+75% +$85.6K ﹤0.01% 1230
2023
Q2 		$122K Buy
+28,245
New +$134K ﹤0.01% 1372
2021
Q2 		– Sell
-2,174
Closed -$13K – 2248
2021
Q1 		$13K Buy
+2,174
New +$20.2K ﹤0.01% 2010
2017
Q2 		– Sell
-349
Closed -$86K – 1615
2017
Q1 		$86K Buy
+349
New +$45.2K ﹤0.01% 1152

Other funds holding IRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Acadian Asset Management's IRD Position: Q4 2023 in Review

Acadian Asset Management sold out of Opus Genetics (IRD) in Q4 2023, closing a stake of 49,563 shares — an estimated $165K sold.

Acadian Asset Management first reported a position in IRD in Q1 2017 and held it in 4 quarters. The position peaked at $165K in Q3 2023. 50 funds tracked by Wall St. Rank hold IRD as of Q4 2023.

  • Acadian Asset Management reported no remaining Opus Genetics position as of Q4 2023 after selling out during the quarter.
  • Acadian Asset Management sold 49,563 Opus Genetics shares in Q4 2023, an estimated $165K.
  • Acadian Asset Management first reported a position in Opus Genetics in Q1 2017 and held it in 4 quarters.
  • Acadian Asset Management's Opus Genetics position peaked at $165K in Q3 2023.
  • 50 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2023.

Based on Acadian Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.